Niagen Bioscience, Inc. (NAGE)

Niagen Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	523	406	108	125	256	297
Market Cap Growth	277.18%	277.18%	-14.15%	-50.96%	-14.02%	15.84%
Enterprise Value	472	377	85	117	226	284
Last Close Price	7.08	5.30	1.43	1.68	3.74	4.80
PE Ratio	60.32	47.50	-	-	-	-
Forward PE	56.87	50.28	-	-	-	-
PS Ratio	5.40	4.08	1.29	1.74	3.79	5.02
PB Ratio	11.90	8.81	3.78	4.37	8.06	18.11
P/TBV Ratio	8.88	8.88	3.85	4.48	8.29	19.39
P/FCF Ratio	42.98	33.99	15.45	-	-	-
P/OCF Ratio	42.40	33.54	15.13	-	-	-
EV/Sales Ratio	4.74	3.78	1.01	1.62	3.35	4.79
EV/EBITDA Ratio	55.22	44.12	-	-	-	-
EV/EBIT Ratio	61.04	48.76	-	-	-	-
EV/FCF Ratio	39.48	31.54	12.17	-	-	-
Debt / Equity Ratio	0.06	0.06	0.12	0.15	0.15	0.10
Debt / EBITDA Ratio	0.27	0.27	-	-	-	-
Debt / FCF Ratio	0.22	0.22	0.47	-	-	-
Asset Turnover	1.62	1.62	1.53	1.29	1.40	1.51
Inventory Turnover	3.21	3.21	2.25	2.07	2.05	2.07
Quick Ratio	2.96	2.96	1.57	1.61	1.89	1.17
Current Ratio	3.57	3.57	2.40	2.61	2.78	1.96
Return on Equity (ROE)	22.94%	22.94%	-17.29%	-54.77%	-112.68%	-108.09%
Return on Assets (ROA)	7.84%	7.84%	-6.42%	-20.81%	-35.18%	-31.57%
Return on Capital (ROIC)	12.00%	12.00%	-10.82%	-33.57%	-62.10%	-61.70%
Return on Capital Employed (ROCE)	15.40%	15.40%	-	-	-	-
Earnings Yield	1.67%	2.10%	-4.59%	-13.19%	-10.61%	-6.70%
FCF Yield	2.33%	2.94%	6.47%	-12.31%	-9.61%	-3.60%
Buyback Yield / Dilution	-4.19%	-4.19%	-7.54%	-3.79%	-10.02%	-7.03%

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.